| Sterling Mckissack, MD | |
|
18511 Highlander Medics St, Fort Bliss, TX 79906-5327 | |
| (915) 742-9273 | |
| Not Available |
| Full Name | Sterling Mckissack |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 10 Years |
| Location | 18511 Highlander Medics St, Fort Bliss, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285033290 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Epiphany Dermatology Pa | 3971827791 | 69 |
News Archive
When it comes to pain, the two competing schools of thought are that it's either "all in your head" or "all in your body". A new study led by University of Oxford researchers indicates that, instead, pain is an amalgam of the two.
The lesbian, gay, bisexual, transgender/transsexual, queer/questioning and intersex (LGBTQI) population has been largely understudied by the medical community. Researchers at Moffitt Cancer Center found that the LGBTQI community experience health disparities due to reduced access to health care and health insurance, coupled with being at an elevated risk for multiple types of cancer when compared to non-LGBTQI populations.
Vion Pharmaceuticals, Inc. has announced that the New Drug Application (NDA) for its lead oncology therapeutic Onrigin (laromustine) Injection has been accepted for review by the U.S. Food and Drug Administration (FDA).
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
› Verified 5 days ago
| Entity Name | Epiphany Dermatology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043615263 PECOS PAC ID: 3971827791 Enrollment ID: O20150126001498 |
News Archive
When it comes to pain, the two competing schools of thought are that it's either "all in your head" or "all in your body". A new study led by University of Oxford researchers indicates that, instead, pain is an amalgam of the two.
The lesbian, gay, bisexual, transgender/transsexual, queer/questioning and intersex (LGBTQI) population has been largely understudied by the medical community. Researchers at Moffitt Cancer Center found that the LGBTQI community experience health disparities due to reduced access to health care and health insurance, coupled with being at an elevated risk for multiple types of cancer when compared to non-LGBTQI populations.
Vion Pharmaceuticals, Inc. has announced that the New Drug Application (NDA) for its lead oncology therapeutic Onrigin (laromustine) Injection has been accepted for review by the U.S. Food and Drug Administration (FDA).
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sterling Mckissack, MD 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, TX 78236-5638 Ph: () - | Sterling Mckissack, MD 18511 Highlander Medics St, Fort Bliss, TX 79906-5327 Ph: (915) 742-9273 |
News Archive
When it comes to pain, the two competing schools of thought are that it's either "all in your head" or "all in your body". A new study led by University of Oxford researchers indicates that, instead, pain is an amalgam of the two.
The lesbian, gay, bisexual, transgender/transsexual, queer/questioning and intersex (LGBTQI) population has been largely understudied by the medical community. Researchers at Moffitt Cancer Center found that the LGBTQI community experience health disparities due to reduced access to health care and health insurance, coupled with being at an elevated risk for multiple types of cancer when compared to non-LGBTQI populations.
Vion Pharmaceuticals, Inc. has announced that the New Drug Application (NDA) for its lead oncology therapeutic Onrigin (laromustine) Injection has been accepted for review by the U.S. Food and Drug Administration (FDA).
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
› Verified 5 days ago